Pressmeddelanden från Bavarian Nordic

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Bavarian Nordic

Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement 02 mar 07:42

Bavarian Nordic

Paul Chaplin Steps Down as CEO of Bavarian Nordic 12 feb 07:43

Bavarian Nordic

Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026 09 feb 09:21

Bavarian Nordic

Bavarian Nordic – Completion of Share Buy-Back Program 02 feb 08:54

Bavarian Nordic

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program 26 jan 08:21

Bavarian Nordic

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program 23 jan 08:00

Bavarian Nordic

Bavarian Nordic Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil 19 jan 08:35

Bavarian Nordic

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program 12 jan 13:17

Bavarian Nordic

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program 07 jan 08:09

Bavarian Nordic

Bavarian Nordic Launches Planned Share Buy-Back Program 18 dec 2025 20:41

Bavarian Nordic

Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees 17 dec 2025 08:30

Bavarian Nordic

Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic 02 dec 2025 08:01

Bavarian Nordic

Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million 26 nov 2025 21:00

Bavarian Nordic

Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen 14 nov 2025 07:37

Bavarian Nordic

Bavarian Nordic Announces Interim Results for the First Nine Months of 2025 13 nov 2025 20:45

Bavarian Nordic

Bavarian Nordic Announces Changes to the Board of Directors 10 nov 2025 21:00

Bavarian Nordic

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley 07 nov 2025 17:30

Bavarian Nordic

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley 06 nov 2025 15:03

Bavarian Nordic

Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed 05 nov 2025 08:30

Bavarian Nordic

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley 04 nov 2025 08:30

Bavarian Nordic

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley 01 nov 2025 10:34

Bavarian Nordic

Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business 31 okt 2025 15:56

Bavarian Nordic

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley 31 okt 2025 14:07

Bavarian Nordic

Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira 31 okt 2025 09:14

Bavarian Nordic

Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox 29 okt 2025 13:29

Bavarian Nordic

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley 28 okt 2025 08:30

Bavarian Nordic

Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines 21 okt 2025 14:46

Bavarian Nordic

Consortium consisting of Nordic Capital and Permira lowers the minimum acceptance condition to 66 2/3% in respect of the takeover offer to the shareholders of Bavarian Nordic 16 okt 2025 07:28

Bavarian Nordic

The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira 15 okt 2025 17:57

Bavarian Nordic

Consortium consisting of Nordic Capital and Permira increases offer price and extends offer period until 5 November 2025 in respect of the takeover offer to the shareholders of Bavarian Nordic 13 okt 2025 08:30

Bavarian Nordic

Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira 09 okt 2025 14:22

Bavarian Nordic

Consortium consisting of Nordic Capital and Permira receives final regulatory approval in respect of its takeover offer to the shareholders of Bavarian Nordic 07 okt 2025 16:56

Bavarian Nordic

Bavarian Nordic Reports Positive Topline Data for Mpox/Smallpox Vaccine in Pediatric Population 29 sep 2025 16:35

Bavarian Nordic

Consortium consisting of Nordic Capital and Permira extends offer period until 14 October 2025 and provides update on regulatory approvals in respect of the takeover offer to the shareholders of Bavarian Nordic 05 sep 2025 10:00

Bavarian Nordic

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise 26 aug 2025 08:15

Bavarian Nordic

Publication of statement by the Board of Directors in respect of the takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira 26 aug 2025 08:09

Bavarian Nordic

Publication of offer document in respect of the takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira and lowering of minimum acceptance condition to 75%22 aug 2025 07:38

Bavarian Nordic

Bavarian Nordic Announces First Half 2025 Results 31 jul 2025 16:33

Bavarian Nordic

Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance 28 jul 2025 08:08

Bavarian Nordic

Consortium Led by Nordic Capital and Permira Will Make All-Cash Recommended Purchase Offer for Bavarian Nordic 24 jul 2025 15:56

Bavarian Nordic

Rumours of a Potential Takeover Offer for Bavarian Nordic A/S 22 jul 2025 08:00

Bavarian Nordic

Bavarian Nordic Receives Acceptance from Health Canada for Review of the New Drug Submission for its Chikungunya Vaccine 09 jul 2025 16:46

Bavarian Nordic

Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country 26 jun 2025 08:00

Bavarian Nordic

Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in Infants and Pregnant Women 18 jun 2025 09:04

Bavarian Nordic

Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million 12 jun 2025 08:00

Bavarian Nordic

Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children 09 maj 2025 17:30

Bavarian Nordic

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such 09 maj 2025 07:38

Bavarian Nordic

Bavarian Nordic Announces Interim Results for the First Three Months of 2025 06 maj 2025 08:56

Bavarian Nordic

Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox/Mpox Vaccines 02 maj 2025 08:30

Bavarian Nordic

Bavarian Nordic Receives Marketing Authorization for Chikungunya Vaccine for Persons Aged 12 and Older in the United Kingdom 16 apr 2025 22:04

Bavarian Nordic

Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)09 apr 2025 18:02

Bavarian Nordic

Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S 09 apr 2025 17:38

Bavarian Nordic

Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S 31 mar 2025 22:38

Bavarian Nordic

Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine 12 mar 2025 12:00

Bavarian Nordic

Bavarian Nordic A/S – Notice Convening Annual General Meeting 07 mar 2025 07:30

Bavarian Nordic

Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older 05 mar 2025 08:08

Bavarian Nordic

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such 05 mar 2025 07:50

Bavarian Nordic

Bavarian Nordic Publishes Annual Report 2024 28 feb 2025 17:14

Bavarian Nordic

Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older 25 feb 2025 07:00

Bavarian Nordic

Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine 14 feb 2025 23:27

Bavarian Nordic

Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older 03 feb 2025 18:24

Bavarian Nordic

Bavarian Nordic Reports Preliminary 2024 Financial Results in Line with Upgraded Guidance and Guides for 2025 31 jan 2025 20:31

Bavarian Nordic

Bavarian Nordic – Completion of Share Buy-Back Program 31 jan 2025 11:50

Bavarian Nordic

Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older 27 jan 2025 07:30

Bavarian Nordic

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program 20 jan 2025 07:30

Bavarian Nordic

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program 09 jan 2025 08:09

Bavarian Nordic

Bavarian Nordic Launches Planned Share Buy-Back Program of DKK 150 Million 16 dec 2024 07:30

Bavarian Nordic

Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India 13 dec 2024 17:30

Bavarian Nordic

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such 13 dec 2024 08:00

Bavarian Nordic

New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic 11 dec 2024 08:14

Bavarian Nordic

Bavarian Nordic to Launch DKK 150 Million Share Buy-back Program 29 nov 2024 17:30

Bavarian Nordic

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such 29 nov 2024 09:49

Bavarian Nordic

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise 15 nov 2024 07:39

Bavarian Nordic

Bavarian Nordic Announces Interim Results for the First Nine Months of 2024 29 okt 2024 07:30

Bavarian Nordic

First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine 26 sep 2024 16:30

Bavarian Nordic

Bavarian Nordic Upgrades its Financial Guidance for 2024 26 sep 2024 16:30

Bavarian Nordic

Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines 24 sep 2024 17:30

Bavarian Nordic

Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines 19 sep 2024 15:45

Bavarian Nordic

Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents 18 sep 2024 10:45

Bavarian Nordic

Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa 16 sep 2024 14:00

Bavarian Nordic

Canada's Only Single-Dose Cholera Vaccine Available Nationwide 13 sep 2024 11:57

Bavarian Nordic

Bavarian Nordic Receives WHO Prequalification for Mpox Vaccine 12 sep 2024 10:54

Bavarian Nordic

Bavarian Nordic Provides Update on the Mpox Vaccine Supply Situation 06 sep 2024 18:00

Bavarian Nordic

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such 05 sep 2024 18:00

Bavarian Nordic

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such 05 sep 2024 13:19

Bavarian Nordic

First Doses of Bavarian Nordic’s Mpox Vaccine Now Arriving in the Democratic Republic of Congo 05 sep 2024 10:22

Bavarian Nordic

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise 27 aug 2024 08:00

Bavarian Nordic

Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Singapore 23 aug 2024 18:00

Bavarian Nordic

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such 22 aug 2024 07:45

Bavarian Nordic

Bavarian Nordic Announces First Half 2024 Results 21 aug 2024 19:30

Bavarian Nordic

Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country 17 aug 2024 13:26

Bavarian Nordic

Bavarian Nordic Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global Stakeholders 16 aug 2024 07:30

Bavarian Nordic

Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to Adolescents 13 aug 2024 22:15

Bavarian Nordic

Bavarian Nordic Receives Order from HERA and Announces Significant Donation of Vaccines in Response to the Mpox Outbreak in Africa 13 aug 2024 19:44

Bavarian Nordic

Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine 08 aug 2024 06:49

Bavarian Nordic

Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production 26 jul 2024 08:00

Bavarian Nordic

Bavarian Nordic Receives Positive CHMP Opinion for Including Mpox Real-world Effectiveness Data in European Marketing Authorization for Smallpox and Mpox Vaccine 18 jul 2024 09:15

Bavarian Nordic

Bavarian Nordic Receives EMA Filing Acceptance and Validation of the MAA for its Chikungunya Vaccine 01 jul 2024 08:30

Bavarian Nordic

Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan 28 jun 2024 16:27

Bavarian Nordic

Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa